Literature DB >> 41551

A pharmacological method of measuring mouth caecal transit time in man.

M Kennedy, P Chinwah, D N Wade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 41551      PMCID： PMC1429828          DOI： 10.1111/j.1365-2125.1979.tb04723.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Absorption, metabolism, and excretion of salicylazosulfapyridine in man.

Authors:  H Schröder; D E Campbell
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

2.  Production and excretion of hydrogen gas in man.

Authors:  M D Levitt
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

3.  Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.

Authors:  H Schröder; R M Lewkonia; D A Price Evans
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

4.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

5.  Delayed small-intestinal transit in tropical malabsorption.

Authors:  G C Cook
Journal:  Br Med J       Date:  1978-07-22
  5 in total
  20 in total

1.  Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers.

Authors:  B Mühlbauer; M Schwenk; W M Coram; K H Antonin; P Etienne; P R Bieck; F L Douglas
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Dose-dependent absorption and elimination of cefadroxil in man.

Authors:  T M Garrigues; U Martin; J E Peris-Ribera; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Fraction of theophylline in sustained-release formulation which is absorbed from the large bowel.

Authors:  D K Sommers; E C Meyer; M van Wyk; J Moncrieff
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Role of fasting gastrointestinal motility in the variability of gastrointestinal transit time assessed by hydrogen breath test.

Authors:  C Di Lorenzo; C P Dooley; J E Valenzuela
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

5.  Plasma concentrations of remoxipride and the gastrointestinal transit of 111In-marked extended-release coated spheres.

Authors:  C Graffner; Z Wagner; M I Nilsson; E Widerlöv
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

6.  Statistical analysis of the lactulose/breath hydrogen test in the measurement of orocaecal transit: its variability and predictive value in assessing drug action.

Authors:  D H Staniforth; D Rose
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

Review 7.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.

Authors:  J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Chloroquine decreases oral-caecal transit time.

Authors:  K K Adjepon-Yamoah; N M Woolhouse; D Ofori-Adjei; L N Nortey
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

9.  Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.

Authors:  Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

10.  Interaction of talinolol and sulfasalazine in the human gastrointestinal tract.

Authors:  B Terhaag; U Palm; H Sahre; K Richter; R Oertel
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.